HKD 0.12
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 15.08 Million HKD | 280.74% |
2022 | 3.96 Million HKD | -78.54% |
2021 | 18.45 Million HKD | -66.45% |
2020 | 55.01 Million HKD | -37.6% |
2019 | 88.15 Million HKD | 38.31% |
2018 | 63.73 Million HKD | -19.11% |
2017 | 78.79 Million HKD | 28.08% |
2016 | 61.52 Million HKD | 30.93% |
2015 | 46.98 Million HKD | 0.0% |
2013 | 27.58 Million HKD | 238.85% |
2012 | 8.14 Million HKD | 1059.54% |
2011 | 702 Thousand HKD | -98.69% |
2010 | 53.4 Million HKD | -46.42% |
2009 | 99.66 Million HKD | 102.18% |
2008 | 49.29 Million HKD | 204.78% |
2007 | 16.17 Million HKD | 298.53% |
2006 | 4.05 Million HKD | 2940.73% |
2005 | 133.46 Thousand HKD | -91.47% |
2004 | 1.56 Million HKD | -23.76% |
2003 | 2.05 Million HKD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 1.48 Million HKD | -88.88% |
2024 Q2 | 1.48 Million HKD | 0.0% |
2023 Q2 | 1.23 Million HKD | 147.0% |
2023 Q4 | 13.34 Million HKD | 72.43% |
2023 Q1 | 500 Thousand HKD | -51.83% |
2023 Q3 | 7.74 Million HKD | 526.72% |
2023 FY | 15.08 Million HKD | 280.74% |
2022 Q3 | 1.68 Million HKD | 131.05% |
2022 Q4 | 1.03 Million HKD | -38.54% |
2022 Q1 | 502 Thousand HKD | -89.58% |
2022 Q2 | 731 Thousand HKD | 45.62% |
2022 FY | 3.96 Million HKD | -78.54% |
2021 Q2 | 2.92 Million HKD | -75.45% |
2021 Q1 | 11.93 Million HKD | 56.99% |
2021 Q3 | 3.29 Million HKD | 12.43% |
2021 Q4 | 4.81 Million HKD | 46.34% |
2021 FY | 18.45 Million HKD | -66.45% |
2020 Q1 | 13.2 Million HKD | -57.23% |
2020 Q3 | 16.16 Million HKD | -10.42% |
2020 Q4 | 7.6 Million HKD | -52.98% |
2020 FY | 55.01 Million HKD | -37.6% |
2020 Q2 | 18.04 Million HKD | 36.62% |
2019 FY | 88.15 Million HKD | 38.31% |
2019 Q4 | 30.88 Million HKD | 42.48% |
2019 Q3 | 21.67 Million HKD | 8.75% |
2019 Q1 | 15.67 Million HKD | 24.25% |
2019 Q2 | 19.93 Million HKD | 27.19% |
2018 FY | 63.73 Million HKD | -19.11% |
2018 Q2 | 14.78 Million HKD | -8.53% |
2018 Q3 | 20.18 Million HKD | 36.59% |
2018 Q4 | 12.61 Million HKD | -37.53% |
2018 Q1 | 16.15 Million HKD | -20.99% |
2017 Q3 | 11.4 Million HKD | -67.62% |
2017 Q1 | 11.71 Million HKD | -53.3% |
2017 FY | 78.79 Million HKD | 28.08% |
2017 Q4 | 20.45 Million HKD | 79.28% |
2017 Q2 | 35.22 Million HKD | 200.73% |
2016 Q1 | 13.11 Million HKD | -10.32% |
2016 Q2 | 11.59 Million HKD | -11.6% |
2016 Q3 | 11.73 Million HKD | 1.24% |
2016 Q4 | 25.08 Million HKD | 113.79% |
2016 FY | 61.52 Million HKD | 30.93% |
2015 FY | 46.98 Million HKD | 0.0% |
2015 Q2 | 10.54 Million HKD | 3.83% |
2015 Q1 | 10.15 Million HKD | 0.0% |
2015 Q3 | 11.66 Million HKD | 10.63% |
2015 Q4 | 14.61 Million HKD | 25.3% |
2014 Q2 | 14.32 Million HKD | 201.01% |
2014 Q3 | 10.92 Million HKD | -23.73% |
2014 Q1 | 4.75 Million HKD | -5.14% |
2013 Q4 | 5.01 Million HKD | 43.89% |
2013 FY | 27.58 Million HKD | 238.85% |
2013 Q1 | 1.01 Million HKD | 16.99% |
2013 Q3 | 3.48 Million HKD | 27.51% |
2013 Q2 | 2.73 Million HKD | 170.16% |
2012 Q1 | - HKD | 0.0% |
2012 FY | 8.14 Million HKD | 1059.54% |
2012 Q3 | 3.51 Million HKD | 400.57% |
2012 Q2 | 702 Thousand HKD | 0.0% |
2012 Q4 | 865 Thousand HKD | -75.38% |
2011 Q3 | - HKD | -100.0% |
2011 Q2 | 7.9 Million HKD | 50.0% |
2011 Q1 | 5.26 Million HKD | -58.06% |
2011 FY | 702 Thousand HKD | -98.69% |
2011 Q4 | - HKD | 0.0% |
2010 Q4 | 12.56 Million HKD | -54.6% |
2010 Q1 | 12.86 Million HKD | -54.57% |
2010 Q2 | 44.63 Million HKD | 247.02% |
2010 Q3 | 27.66 Million HKD | -38.01% |
2010 FY | 53.4 Million HKD | -46.42% |
2009 Q3 | 13.85 Million HKD | -43.57% |
2009 Q1 | 9.16 Million HKD | 10.85% |
2009 FY | 99.66 Million HKD | 102.18% |
2009 Q4 | 28.31 Million HKD | 104.32% |
2009 Q2 | 24.55 Million HKD | 168.02% |
2008 FY | 49.29 Million HKD | 204.78% |
2008 Q4 | 8.26 Million HKD | 13.05% |
2008 Q3 | 7.31 Million HKD | 0.0% |
2007 FY | 16.17 Million HKD | 298.53% |
2006 FY | 4.05 Million HKD | 2940.73% |
2005 FY | 133.46 Thousand HKD | -91.47% |
2004 FY | 1.56 Million HKD | -23.76% |
2003 FY | 2.05 Million HKD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 336.01 Million HKD | 95.512% |
Innovative Pharmaceutical Biotech Limited | 6.59 Million HKD | -128.743% |
China Overseas Nuoxin International Holdings Limited | 180.99 Million HKD | 91.668% |
Prosperous Future Holdings Limited | 470.33 Million HKD | 96.794% |
Huasheng International Holding Limited | 565.9 Million HKD | 97.335% |
Fourace Industries Group Holdings Limited | 268.02 Million HKD | 94.373% |
Evergreen Products Group Limited | 979.24 Million HKD | 98.46% |
EC Healthcare | 4.21 Billion HKD | 99.642% |
Ming Fai International Holdings Limited | 2.06 Billion HKD | 99.27% |
Blue Moon Group Holdings Limited | 7.32 Billion HKD | 99.794% |
Takbo Group Holdings Limited | 215.59 Million HKD | 93.005% |
Hyfusin Group Holdings Limited | 866.25 Million HKD | 98.259% |